---
name: Burrard Pharmaceuticals
slug: burrardpharma
site: cdmo
website_domain: burrardpharma.com
summary: Vancouver-based CDMO delivering technology transfer, formulation development, and GMP manufacturing for 75+ molecules across oncology, diabetes, and respiratory therapeutics since 2005. Headquartered in Vancouver, Canada.
tagline: Technology transfer, formulation development, and GMP manufacturing for 75+ molecules across oncology, diabetes, and respiratory.
founded_year: 2005
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: CA
tier2_domain_verified: false
updated_at: 2026-09-13T07:01:27.335Z
services_count: 15
modalities_count: 3
indications_count: 4
locations_count: 1
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# Burrard Pharmaceuticals

Technology transfer, formulation development, and GMP manufacturing for 75+ molecules across oncology, diabetes, and respiratory.

Listed on cdmo.directory.

## Summary

Vancouver-based CDMO delivering technology transfer, formulation development, and GMP manufacturing for 75+ molecules across oncology, diabetes, and respiratory therapeutics since 2005. Headquartered in Vancouver, Canada.

## At a glance

- Founded: 2005
- HQ country: CA

## Services

- Technology Transfer
- Formulation Development
- CMC Regulatory Submission Support
- CMC Analytical Development
- Stability Testing & Storage
- Quality Control Testing
- Process Development
- Sterile Fill-Finish & Aseptic Manufacturing
- Vial Filling
- Oral Solid Dosage Manufacturing
- Ophthalmic Manufacturing
- Topical & Semi-Solid Manufacturing
- Secondary Packaging & Labeling
- Cold-Chain Storage & Logistics
- Serialization & Track-and-Trace

## Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)

## Indications

- Oncology
- Metabolic
- Respiratory
- Immunology

## Locations

- Headquarters, Vancouver, British Columbia, Canada

## Long description

## Overview

Burrard Pharmaceuticals is a Vancouver-based Contract Development and Manufacturing Organization (CDMO) established in 2005. The company specializes in technology transfer, formulation development, regulatory services, and GMP-compliant contract manufacturing across small molecules, biologics, and complex generics.

## Core Services

**Technology Transfer:** Seamless transfer of manufacturing processes, analytical methods, and regulatory documentation for 75+ molecules. Each package includes process validation protocols, analytical method validation, stability study designs, and complete regulatory documentation.

**Formulation Development:** AI-assisted formulation optimization for small molecules, biologics, and complex generics. Capabilities include pre-formulation studies, prototype development, scale-up optimization, and real-time stability simulations.

**Contract Manufacturing:** GMP-compliant manufacturing for sterile injectables, oral solids, ophthalmic products, and topical formulations. Services include batch manufacturing, process validation, packaging and labeling, cold chain management, and commercial-scale production. Facilities meet FDA, EMA, and Health Canada standards.

**Regulatory Services:** Complete CTD/eCTD preparation, submission management, and deficiency response for global regulatory authorities. Burrard Intelligence subscription provides unlimited template requests with 48-hour delivery and monthly regulatory reports.

**Analytical Services:** Method development, validation, stability testing, and release testing for all dosage forms.

**Quality Assurance:** Comprehensive QA/QC systems, deviation management, CAPA, and regulatory audit preparation.

## Therapeutic Focus

The company has demonstrated expertise across:
- Oncology injectables (biosimilars including Trastuzumab, Bevacizumab, Rituximab, Pembrolizumab; chemotherapy agents including Paclitaxel, Docetaxel, Carboplatin)
- Diabetes & GLP-1 therapeutics (Semaglutide, Tirzepatide, Liraglutide, Dulaglutide, insulin formulations)
- Respiratory & immunology (Dupilumab, Omalizumab, Secukinumab, Ustekinumab, Fluticasone combinations)

## Related companies

- [Adragos Pharma](/companies/adragos-pharma) (Technology Transfer, Formulation Development) — [Compare](/compare/adragos-pharma/burrardpharma)
- [Akums Drugs and Pharmaceuticals Ltd.](/companies/akums) (Technology Transfer, Formulation Development) — [Compare](/compare/akums/burrardpharma)
- [Bend Bioscience](/companies/bend-bioscience) (Technology Transfer, Formulation Development) — [Compare](/compare/bend-bioscience/burrardpharma)
- [Vetter Pharma](/companies/vetter-pharma) (Technology Transfer, Formulation Development) — [Compare](/compare/burrardpharma/vetter-pharma)
- [Delpharm](/companies/delpharm) (Technology Transfer, Formulation Development) — [Compare](/compare/burrardpharma/delpharm)
- [Lupin Limited](/companies/lupin) (Technology Transfer, Formulation Development) — [Compare](/compare/burrardpharma/lupin)
- [Lifecore](/companies/lifecore) (Formulation Development, CMC Regulatory Submission Support) — [Compare](/compare/burrardpharma/lifecore)
- [UPM Pharmaceuticals](/companies/upm-inc) (Technology Transfer, Formulation Development) — [Compare](/compare/burrardpharma/upm-inc)

_Profile last updated: 2026-09-13T07:01:27.335Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.